LightOx
We are developing therapeutics to target the most common oral cancer using a simple local delivery system that combines both diagnostic and therapeutic capabilities. This approach enables early identification of oral squamous cell carcinoma and instant treatment by inducing apoptosis (natural cell death) of the selected cells and tissues with minimal damage to healthy cells.
“We target the most common oral cancer using a simple local delivery system.”